Canada markets closed

Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
2.100+0.020 (+0.96%)
As of 03:48PM HKT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
0
0
0
0
0
-
Operating Expenses
Research Development
111,743
111,743
157,830
214,228
245,743
-
Selling General and Administrative
16,090
16,090
13,266
29,737
81,556
-
Total Operating Expenses
163,676
163,676
251,114
403,777
324,268
-
Operating Income or Loss
-163,676
-163,676
-251,114
-403,777
-324,268
-
Interest Expense
578
578
959
685
56
-
Income Before Tax
-188,820
-188,820
-230,868
-409,825
-340,294
-
Income Tax Expense
0
0
0
0
0
-
Income from Continuing Operations
-188,820
-188,820
-230,868
-409,825
-340,294
-
Net Income
-175,893
-175,893
-204,236
-361,449
-325,523
-
Net Income available to common shareholders
-175,893
-175,893
-204,236
-361,449
-325,523
-
Basic EPS
-0.77
-
-0.84
-1.64
-1.37
-0.10
Diluted EPS
-0.77
-
-0.84
-1.64
-1.37
-0.10
Basic Average Shares
243,485
-
243,745
220,590
237,937
237,937
Diluted Average Shares
243,485
-
243,745
220,590
237,937
237,937